FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign
This article was originally published in The Tan Sheet
Executive Summary
FDA is "very seriously" looking into labeling changes for OTC pain relievers, according to outgoing Associate Commissioner for External Relations Peter Pitts
You may also be interested in...
Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Wyeth Consumer Healthcare will revise labeling for two of its analgesic products to include more explicit warnings following FDA approval on Aug. 30
Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Wyeth Consumer Healthcare will revise labeling for two of its analgesic products to include more explicit warnings following FDA approval on Aug. 30
Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Wyeth Consumer Healthcare will revise labeling for two of its analgesic products to include more explicit warnings following FDA approval on Aug. 30